Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 3
2008 3
2009 3
2010 4
2011 2
2012 3
2013 2
2014 1
2016 3
2017 5
2018 2
2019 8
2020 3
2021 3
2022 1
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Predictive and prognostic biomarkers in urological tumours.
Cimadamore A, Franzese C, Di Loreto C, Blanca A, Lopez-Beltran A, Crestani A, Giannarini G, Tan PH, Carneiro BA, El-Deiry WS, Montironi R, Cheng L. Cimadamore A, et al. Among authors: blanca a. Pathology. 2024 Mar;56(2):228-238. doi: 10.1016/j.pathol.2023.10.016. Epub 2023 Dec 14. Pathology. 2024. PMID: 38199927 Review.
The Identification of Immunological Biomarkers in Kidney Cancers.
Lopez-Beltran A, Henriques V, Cimadamore A, Santoni M, Cheng L, Gevaert T, Blanca A, Massari F, Scarpelli M, Montironi R. Lopez-Beltran A, et al. Among authors: blanca a. Front Oncol. 2018 Nov 2;8:456. doi: 10.3389/fonc.2018.00456. eCollection 2018. Front Oncol. 2018. PMID: 30450335 Free PMC article. Review.
Immunotherapy in renal cell carcinoma from poverty to the spoiled of choice.
Massari F, Nunno VD, Mollica V, Montironi R, Cheng L, Cimadamore A, Blanca A, Lopez-Beltran A. Massari F, et al. Among authors: blanca a. Immunotherapy. 2019 Dec;11(17):1507-1521. doi: 10.2217/imt-2019-0115. Epub 2019 Oct 30. Immunotherapy. 2019. PMID: 31663411 Review.
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer.
Lopez-Beltran A, Cimadamore A, Blanca A, Massari F, Vau N, Scarpelli M, Cheng L, Montironi R. Lopez-Beltran A, et al. Among authors: blanca a. Cancers (Basel). 2021 Jan 3;13(1):131. doi: 10.3390/cancers13010131. Cancers (Basel). 2021. PMID: 33401585 Free PMC article. Review.
Tp53 and its potential therapeutic role as a target in bladder cancer.
Ciccarese C, Massari F, Blanca A, Tortora G, Montironi R, Cheng L, Scarpelli M, Raspollini MR, Vau N, Fonseca J, Lopez-Beltran A. Ciccarese C, et al. Among authors: blanca a. Expert Opin Ther Targets. 2017 Apr;21(4):401-414. doi: 10.1080/14728222.2017.1297798. Epub 2017 Mar 1. Expert Opin Ther Targets. 2017. PMID: 28281901 Review.
Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
Lopez-Beltran A, Cheng L, Gevaert T, Blanca A, Cimadamore A, Santoni M, Massari F, Scarpelli M, Raspollini MR, Montironi R. Lopez-Beltran A, et al. Among authors: blanca a. Expert Rev Mol Diagn. 2020 Feb;20(2):231-243. doi: 10.1080/14737159.2020.1699791. Epub 2019 Dec 11. Expert Rev Mol Diagn. 2020. PMID: 31795775 Review.
Lymphoepithelioma-like carcinoma of the upper urinary tract.
Lopez-Beltran A, Paner G, Blanca A, Montironi R, Tsuzuki T, Nagashima Y, Chuang SS, Win KT, Madruga L, Raspollini MR, Cheng L. Lopez-Beltran A, et al. Among authors: blanca a. Virchows Arch. 2017 Jun;470(6):703-709. doi: 10.1007/s00428-017-2117-z. Epub 2017 Apr 28. Virchows Arch. 2017. PMID: 28455741
50 results